HUM vs ISPC
Humana Inc (HUM) versus iSpecimen Inc (ISPC) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. ISPC currently screens at market cap $4.4M.
Not investment advice. Open the HUM and ISPC stock pages for the full models.
Not investment advice.